Header Logo

Connection

JASVINDER SINGH to Rheumatology

Back to Details
This is a "connection" page, showing publications JASVINDER SINGH has written about Rheumatology.
JASVINDER SINGH
Connection Strength
17.553
Rheumatology
  1. Barriers to and facilitators of sustaining a systemic lupus erythematosus (SLE) patient decision aid in regular rheumatology outpatient care in the USA. Rheumatology (Oxford). 2025 Jun 01; 64(6):3580-3586.
    View in: PubMed
    Score: 0.846
  2. 2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective. J Arthroplasty. 2023 11; 38(11):2193-2201.
    View in: PubMed
    Score: 0.753
  3. 2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective. Arthritis Care Res (Hoboken). 2023 11; 75(11):2227-2238.
    View in: PubMed
    Score: 0.753
  4. 2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective. Arthritis Rheumatol. 2023 11; 75(11):1877-1888.
    View in: PubMed
    Score: 0.753
  5. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. Arthritis Rheumatol. 2022 09; 74(9):1464-1473.
    View in: PubMed
    Score: 0.690
  6. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. Arthritis Care Res (Hoboken). 2022 09; 74(9):1399-1408.
    View in: PubMed
    Score: 0.689
  7. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. J Arthroplasty. 2022 09; 37(9):1676-1683.
    View in: PubMed
    Score: 0.689
  8. Telemedicine Use During the COVID-19 Pandemic by Resilient Rheumatology Providers: A National Veterans Affairs Follow-up Survey. J Rheumatol. 2022 04; 49(4):424-431.
    View in: PubMed
    Score: 0.672
  9. Telemedicine Including Video-Based Visits in Rheumatology in COVID-19 Pandemic: Not Yet Ideal. J Clin Rheumatol. 2022 Jan 01; 28(1):e292-e293.
    View in: PubMed
    Score: 0.668
  10. Organizational context and the learning and change readiness climate for implementing an evidence-based shared decision-making aid in US rheumatology clinics. J Health Organ Manag. 2021 Jul 08; ahead-of-print(ahead-of-print).
    View in: PubMed
    Score: 0.646
  11. Management of Rheumatic Diseases During the COVID-19 Pandemic: A National Veterans Affairs Survey of Rheumatologists. Arthritis Care Res (Hoboken). 2021 07; 73(7):998-1003.
    View in: PubMed
    Score: 0.645
  12. Shared decision-making in gout treatment: a national study of rheumatology provider opinion and practice. Clin Rheumatol. 2021 Feb; 40(2):693-700.
    View in: PubMed
    Score: 0.612
  13. Challenges of Practicing Rheumatology in a Government Setting: A County Hospital and Veterans Affairs Hospital Perspective. Rheum Dis Clin North Am. 2019 02; 45(1):39-51.
    View in: PubMed
    Score: 0.545
  14. The Third Biennial 2018 OMERACT First-time Participant Program: A Qualitative and Quantitative Study. J Rheumatol. 2019 08; 46(8):1036-1040.
    View in: PubMed
    Score: 0.544
  15. Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis Care Res (Hoboken). 2019 01; 71(1):2-29.
    View in: PubMed
    Score: 0.539
  16. The OMERACT First-time Participant Program: Fresh Eye from the New Guys. J Rheumatol. 2017 Oct; 44(10):1560-1563.
    View in: PubMed
    Score: 0.484
  17. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2016 Jan; 68(1):1-25.
    View in: PubMed
    Score: 0.436
  18. OMERACT 11: international consensus conference on outcome measures in rheumatology. J Rheumatol. 2014 Jan; 41(1):145-9.
    View in: PubMed
    Score: 0.383
  19. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012 May; 64(5):625-39.
    View in: PubMed
    Score: 0.342
  20. A national survey of Veterans Affairs rheumatologists for relevance of quality of care indicators for gout management. Arthritis Care Res (Hoboken). 2010 Sep; 62(9):1306-11.
    View in: PubMed
    Score: 0.304
  21. Development of classification and response criteria for rheumatic diseases. Arthritis Rheum. 2006 Jun 15; 55(3):348-52.
    View in: PubMed
    Score: 0.227
  22. Core domain set for studies of acute calcium pyrophosphate crystal arthritis: OMERACT delphi survey to establish consensus. Semin Arthritis Rheum. 2025 Jun; 72:152670.
    View in: PubMed
    Score: 0.208
  23. Contraception Care Patterns for Adult Females With Juvenile Idiopathic Arthritis on Teratogens in the Rheumatology Informatics System for Effectiveness (RISE) Registry. J Rheumatol. 2024 May 01; 51(5):542-545.
    View in: PubMed
    Score: 0.196
  24. Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials. Semin Arthritis Rheum. 2024 04; 65:152381.
    View in: PubMed
    Score: 0.192
  25. Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group. Semin Arthritis Rheum. 2023 12; 63:152288.
    View in: PubMed
    Score: 0.189
  26. Telemedicine in rheumatology care: A systematic review. Semin Arthritis Rheum. 2022 10; 56:152045.
    View in: PubMed
    Score: 0.172
  27. Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. RMD Open. 2021 09; 7(3).
    View in: PubMed
    Score: 0.163
  28. Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group. Semin Arthritis Rheum. 2021 08; 51(4):946-950.
    View in: PubMed
    Score: 0.161
  29. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2021 07; 73(7):924-939.
    View in: PubMed
    Score: 0.160
  30. OMERACT 2020: A virtual (R)evolution. Semin Arthritis Rheum. 2021 06; 51(3):588-592.
    View in: PubMed
    Score: 0.159
  31. Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach. Semin Arthritis Rheum. 2021 06; 51(3):593-600.
    View in: PubMed
    Score: 0.159
  32. OMERACT consensus-based operational definition of contextual factors in rheumatology clinical trials: A mixed methods study. Semin Arthritis Rheum. 2021 06; 51(3):601-606.
    View in: PubMed
    Score: 0.158
  33. Outcome domains reported by patients, caregivers, healthcare professionals and stakeholders for calcium pyrophosphate deposition (CPPD): A content analysis based on semi-structured qualitative interviews from the OMERACT CPPD working group. Semin Arthritis Rheum. 2021 06; 51(3):650-654.
    View in: PubMed
    Score: 0.156
  34. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Rheumatol. 2020 06; 72(6):879-895.
    View in: PubMed
    Score: 0.149
  35. Factors influencing implementation of a computerized, individualized, culturally tailored lupus decision aid in lupus clinics: a qualitative semi-structured interview study. Clin Rheumatol. 2019 Oct; 38(10):2793-2801.
    View in: PubMed
    Score: 0.140
  36. Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology. J Rheumatol. 2019 08; 46(8):1014-1020.
    View in: PubMed
    Score: 0.137
  37. Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology. J Rheumatol. 2019 08; 46(8):1028-1035.
    View in: PubMed
    Score: 0.136
  38. OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions. J Rheumatol. 2019 10; 46(10):1409-1414.
    View in: PubMed
    Score: 0.136
  39. Identifying Provisional Generic Contextual Factor Domains for Clinical Trials in Rheumatology: Results from an OMERACT Initiative. J Rheumatol. 2019 09; 46(9):1159-1163.
    View in: PubMed
    Score: 0.136
  40. Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis Rheumatol. 2019 01; 71(1):5-32.
    View in: PubMed
    Score: 0.135
  41. Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelines. Clin Rheumatol. 2018 Nov; 37(11):2947-2959.
    View in: PubMed
    Score: 0.132
  42. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017 12; 76(12):1955-1964.
    View in: PubMed
    Score: 0.125
  43. 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups. Arthritis Rheumatol. 2017 12; 69(12):2271-2282.
    View in: PubMed
    Score: 0.125
  44. Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument Sets. J Rheumatol. 2017 Oct; 44(10):1551-1559.
    View in: PubMed
    Score: 0.123
  45. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. Arthritis Care Res (Hoboken). 2017 08; 69(8):1111-1124.
    View in: PubMed
    Score: 0.122
  46. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. J Arthroplasty. 2017 09; 32(9):2628-2638.
    View in: PubMed
    Score: 0.122
  47. Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group. J Rheumatol. 2017 Nov; 44(11):1727-1733.
    View in: PubMed
    Score: 0.119
  48. Development of the American College of Rheumatology's Rheumatoid Arthritis Electronic Clinical Quality Measures. Arthritis Care Res (Hoboken). 2016 11; 68(11):1579-1590.
    View in: PubMed
    Score: 0.117
  49. When Patients Write the Guidelines: Patient Panel Recommendations for the Treatment of Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2016 Jan; 68(1):26-35.
    View in: PubMed
    Score: 0.109
  50. Updating the OMERACT filter: discrimination and feasibility. J Rheumatol. 2014 May; 41(5):1005-10.
    View in: PubMed
    Score: 0.098
  51. Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of "truth": content, face, and construct validity. J Rheumatol. 2014 May; 41(5):1000-4.
    View in: PubMed
    Score: 0.098
  52. Updating the OMERACT filter: core areas as a basis for defining core outcome sets. J Rheumatol. 2014 May; 41(5):994-9.
    View in: PubMed
    Score: 0.097
  53. How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0. J Rheumatol. 2014 May; 41(5):1025-30.
    View in: PubMed
    Score: 0.097
  54. Updating the OMERACT filter: implications for imaging and soluble biomarkers. J Rheumatol. 2014 May; 41(5):1016-24.
    View in: PubMed
    Score: 0.097
  55. OMERACT endorsement of measures of outcome for studies of acute gout. J Rheumatol. 2014 Mar; 41(3):569-73.
    View in: PubMed
    Score: 0.096
  56. Including health equity considerations in development of instruments for rheumatology research: an introduction to a novel OMERACT paradigm. J Rheumatol. 2014 Jan; 41(1):150-2.
    View in: PubMed
    Score: 0.094
  57. Serum urate in chronic gout--will it be the first validated soluble biomarker in rheumatology? J Rheumatol. 2011 Jul; 38(7):1462-6.
    View in: PubMed
    Score: 0.081
  58. A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout. Ann Rheum Dis. 2008 Jun; 67(6):888-91.
    View in: PubMed
    Score: 0.063
  59. Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensus. Semin Arthritis Rheum. 2025 Jun; 72:152669.
    View in: PubMed
    Score: 0.052
  60. OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments. Semin Arthritis Rheum. 2024 04; 65:152344.
    View in: PubMed
    Score: 0.048
  61. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheumatol. 2021 07; 73(7):1108-1123.
    View in: PubMed
    Score: 0.040
  62. Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018. J Rheumatol. 2019 10; 46(10):1355-1359.
    View in: PubMed
    Score: 0.034
  63. OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies. J Rheumatol. 2019 08; 46(8):1021-1027.
    View in: PubMed
    Score: 0.034
  64. Addressing Challenges in Developing a Core Domain Set in Adherence Interventions in Rheumatology: A Report from the OMERACT-Adherence Group. J Rheumatol. 2019 09; 46(9):1202-1206.
    View in: PubMed
    Score: 0.034
  65. Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region: an exemplar of the GRADE Adolopment. Health Qual Life Outcomes. 2017 Sep 21; 15(1):183.
    View in: PubMed
    Score: 0.031
  66. Validating Rheumatoid Arthritis Remission Using the Patients' Perspective: Results from a Special Interest Group at OMERACT 2016. J Rheumatol. 2017 Dec; 44(12):1889-1893.
    View in: PubMed
    Score: 0.031
  67. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. Arthritis Rheumatol. 2017 08; 69(8):1538-1551.
    View in: PubMed
    Score: 0.030
  68. Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. J Clin Epidemiol. 2014 Jul; 67(7):745-53.
    View in: PubMed
    Score: 0.024
  69. OMERACT 10 Patient Perspective Virtual Campus: valuing health; measuring outcomes in rheumatoid arthritis fatigue, RA sleep, arthroplasty, and systemic sclerosis; and clinical significance of changes in health. J Rheumatol. 2011 Aug; 38(8):1728-34.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.